Literature DB >> 1941821

Alopecia in systemic lupus erythematosus. Relation to disease manifestations.

A J Wysenbeek1, L Leibovici, M Amit, A Weinberger.   

Abstract

Alopecia was observed in 40/74 (54%) patients with systemic lupus erythematosus (SLE). Patients with alopecia had a significantly higher rating for cutaneous manifestations, Raynaud's phenomenon and muscle tenderness, and most of these signs correlated with the magnitude of alopecia. There was no difference between patients with or without alopecia for arthritis, nephritis or central nervous system manifestations. Alopecia correlated with disease activity index but did not correlate with various specific measurements of disease exacerbation.

Entities:  

Mesh:

Year:  1991        PMID: 1941821

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Rash in systemic lupus erythematosus: prevalence and relation to cutaneous and non-cutaneous disease manifestations.

Authors:  A J Wysenbeek; D Guedj; M Amit; A Weinberger
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Overview of Alopecia: A Dermatopathologist's Perspective.

Authors:  Claudia I Vidal
Journal:  Mo Med       Date:  2015 Jul-Aug

3.  Alopecias in lupus erythematosus.

Authors:  Josef Symon Salgado Concha; Victoria P Werth
Journal:  Lupus Sci Med       Date:  2018-10-25

4.  Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus.

Authors:  Yirong Xiang; Mengtao Li; Hui Luo; Yanhong Wang; Xinwang Duan; Cheng Zhao; Feng Zhan; Zhenbiao Wu; Hongbin Li; Min Yang; Jian Xu; Wei Wei; Lijun Wu; Hanxiao You; Junyan Qian; Xiaoxi Yang; Can Huang; Jiuliang Zhao; Qian Wang; Xiaomei Leng; Xinping Tian; Yan Zhao; Xiaofeng Zeng
Journal:  Arthritis Res Ther       Date:  2021-01-11       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.